28 Dec 2018 IMU School of Pharmacy Lecturer Achieves Cumulative Impact Factor of More than 50 for Research Publications
A Senior Lecturer from the Life Sciences Department of International Medical University (IMU), Dr Dinesh Kumar Chellappan achieved a cumulative Impact Factor (ISI) of 59.968 for his research publications in 2018. Although, he has been actively publishing research papers for the past several years, the year 2018 has been a highly productive year in terms of his research output, where there was a significant increase in the number of papers that were published by him. Most of these papers have come from his own research projects and several others through his collaborators and students.
Most importantly, all of his publications in 2018 were published in journals with ISI impact factor. Several of these publications are published in Tier 1 journals. As a Corresponding Author, he has published 4 research/review papers in the year 2018 with a cumulative impact factor of 13.774. In addition to the above, Dr Dinesh Kumar Chellappan has also published a number of research publications as a Co-Author. In total, he has published 25 research publications with a cumulative Impact factor of 59.968 in 2018. All the papers had ISI impact factor.
The highest impact factor that he achieved was 3.9, in the journal, Colloids and Surfaces B: Biointerfaces (Elsevier). This particular paper was an outcome of a collaborative research work between the International Medical University (IMU), the University of Newcastle and the University of Technology Sydney.
A total of 7 publications were published in Tier 1 journals, and another 16 papers were published in Tier 3 journals. There were 2 papers that were published in journals with no tier. The major Tier 1 journals were Biomedicine and Pharmacotherapy journal (Elsevier) and Colloids and Surfaces B: Biointerfaces (Elsevier).
There were also a good number of papers that were published from the research projects of students from the IMU undergraduate pharmacy programme. Moreover, several of his publications were from the academic curriculum, namely the Current Trends and Therapeutics (CTT) module in BPharm Semester 6, where students are encouraged to write a review, supervised by their lecturers. However, a large number of his publications were published through collaborative research.